The effects of c-Abl mutation on developing B cell differentiation and survival

International Immunology

Volumn 21, Issue 5, 2009, Pages 575-585

  Brightbill, Hans ^a,b   Schlissel, Mark S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GENENTECH INC   (United States)

Author keywords

Apoptosis; B cell development; c Abl; CD19; pre BCR

Indexed keywords

ABELSON KINASE; CALCIUM ION; CD19 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 2 RECEPTOR ALPHA; PROTEIN BCL X;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CALCIUM TRANSPORT; CELL GROWTH; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENE REARRANGEMENT; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; SIGNAL TRANSDUCTION; TRANSGENE;

ANIMALS; ANTIGENS, CD19; APOPTOSIS; CALCIUM; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; INTERLEUKIN-7; MICE; MICE, KNOCKOUT; MUTATION; PRECURSOR CELLS, B-LYMPHOID; PROTO-ONCOGENE PROTEINS C-ABL; RECOMBINANT PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 65549142721     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxp027     Document Type: Article

References (51)

1. Pendergast, A. M. 2002. The Abl family kinases: Mechanisms of regulation and signaling. Adv. Cancer Res. 85:51.
2. Plattner, R., Kadlec, L., DeMali, K. A., Kazlauskas, A. and Pendergast, A. M. 1999. c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. Genes Dev. 13:2400.
3. Heisterkamp, N., Stephenson, J. R., Groffen, J. et al. 1983. Localization of the c-Ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature 306:239.
4. Kipreos, E. T. and Wang, J. Y. 1992. Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA. Science 256:382.
5. McWhirter, J. R. and Wang, J. Y. 1993. An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J. 12:1533.
6. Ren, R., Ye, Z. S. and Baltimore, D. 1994. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes Dev. 8:783.
7. Taagepera, S., McDonald, D., Loeb, J. E. et al. 1998. Nuclearcytoplasmic shuttling of C-ABL tyrosine kinase. Proc. Natl Acad. Sci. USA 95:7457.
8. Wen, S. T., Jackson, P. K. and Van Etten, R. A. 1996. The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products. EMBO J. 15:1583.
9. Lewis, J. M., Baskaran, R., Taagepera, S., Schwartz, M. A. and Wang, J. Y. 1996. Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport. Proc. Natl Acad. Sci. USA 93:15174.
10. Koleske, A. J., Gifford, A. M., Scott, M. L. et al. 1998. Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron 21:1259.
11. Schwartzberg, P. L., Stall, A. M., Hardin, J. D. et al. 1991. Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell 65:1165.
12. Tybulewicz, V. L., Crawford, C. E., Jackson, P. K., Bronson, R. T. and Mulligan, R. C. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-Abl proto-oncogene. Cell 65:1153.
13. Li, B., Boast, S., de los Santos, K. et al. 2000. Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation. Nat. Genet. 24:304.
14. Corcoran, A. E., Riddell, A., Krooshoop, D. and Venkitaraman, A. R. 1998. Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor. Nature 391:904.
15. Fleming, H. E. and Paige, C. J. 2001. Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinase-dependent pathway. Immunity 15:521.
16. Bassing, C. H., Swat, W. and Alt, F. W. 2002. The mechanism and regulation of chromosomal V(D)J recombination. Cell 109 (Suppl):S45.
17. Geier, J. K. and Schlissel, M. S. 2006. Pre-BCR signals and the control of Ig gene rearrangements. Semin Immunol. 18:31.
18. Engel, P., Zhou, L. J., Ord, D. C., Sato, S., Koller, B. and Tedder, T. F. 1995. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3:39.
19. Muljo, S. A. and Schlissel, M. S. 2003. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre- B cell lines. Nat. immunol. 4:31.
20. Roose, J. P., Diehn, M., Tomlinson, M. G. et al. 2003. T cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression. PLoS Biol. 1:E53.
21. Zipfel, P. A., Grove, M., Blackburn, K., Fujimoto, M., Tedder, T. F. and Pendergast, A. M. 2000. The c-Abl tyrosine kinase is regulated downstream of the B cell antigen receptor and interacts with CD19. J. Immunol. 165:6872.
22. Dorsch, M. and Goff, S. P. 1996. Increased sensitivity to apoptotic stimuli in c-Abl-deficient progenitor B-cell lines. Proc. Natl Acad. Sci. USA 93:13131.
23. Hardin, J. D., Boast, S., Schwartzberg, P. L. et al. 1995. Bone marrow B lymphocyte development in c-abl-deficient mice. Cell. Immunol. 165:44.
24. Lam, Q. L., Lo, C. K., Zheng, B. J. et al. 2007. Impaired V(D)J recombination and increased apoptosis among B cell precursors in the bone marrow of c-Abl-deficient mice. Int. Immunol. 19:267.
25. Nussenzweig, M. C., Shaw, A. C., Sinn, E. et al. 1987. Allelic exclusion in transgenic mice that express the membrane form of immunoglobulin mu. Science 236:816.
26. Donehower, L. A., Harvey, M., Slagle, B. L. et al. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215.
27. Brasher, B. B. and Van Etten, R. A. 2000. c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines. J. Biol. Chem. 275:35631.
28. Li, Y. S., Wasserman, R., Hayakawa, K. and Hardy, R. R. 1996. Identification of the earliest B lineage stage in mouse bone marrow. Immunity 5:527.
29. Rolink, A., Grawunder, U., Winkler, T. H., Karasuyama, H. and Melchers, F. 1994. IL-2 receptor alpha chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. Int. Immunol. 6:1257.
30. Fang, W., Mueller, D. L., Pennell, C. A. et al. 1996. Frequent aberrant immunoglobulin gene rearrangements in pro-B cells revealed by a bcl-xL transgene. Immunity 4:291.
31. Schlissel, M., Constantinescu, A., Morrow, T., Baxter, M. and Peng, A. 1993. Double-strand signal sequence breaks in V(D)J recombination are blunt, 5′-phosphorylated, RAG-dependent, and cell cycle regulated. Genes Dev. 7:2520.
32. Whang, Y. E., Tran, C., Henderson, C. et al. 2000. c-Abl is required for development and optimal cell proliferation in the context of p53 deficiency. Proc. Natl Acad. Sci. USA 97:5486.
33. Krop, I., Shaffer, A. L., Fearon, D. T. and Schlissel, M. S. 1996. The signaling activity of murine CD19 is regulated during cell development. J. Immunol. 157:48.
34. Otero, D. C. and Rickert, R. C. 2003. CD19 function in early and late B cell development. II. CD19 facilitates the pro-B/pre-B transition. J. Immunol. 171:5921.
35. Kee, B. L., Bain, G. and Murre, C. 2002. IL-7Ralpha and E47: Independent pathways required for development of multipotent lymphoid progenitors. EMBO J. 21:103.
36. Goga, A., Liu, X., Hambuch, T. M. et al. 1995. p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase. Oncogene 11:791.
37. Sawyers, C. L., McLaughlin, J., Goga, A., Havlik, M. and Witte, O. 1994. The nuclear tyrosine kinase c-Abl negatively regulates cell growth. Cell 77:121.
38. Yuan, Z. M., Huang, Y., Whang, Y. et al. 1996. Role for c-Abl tyrosine kinase in growth arrest response to DNA damage. Nature 382:272.
39. Rosti, V., Bergamaschi, G., Lucotti, C. et al. 1995. Oligodeoxynucleotides antisense to c-abl specifically inhibit entry into S-phase of CD34+ hematopoietic cells and their differentiation to granulocyte-macrophage progenitors. Blood 86:3387.
40. Daniel, R., Cai, Y., Wong, P. M. and Chung, S. W. 1995. Deregulation of c-Abl mediated cell growth after retroviral transfer and expression of antisense sequences. Oncogene 10:1607.
41. Kharbanda, S., Ren, R., Pandey, P. et al. 1995. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 376:785.
42. Gu, J. J., Zhang, N., He, Y. W., Koleske, A. J. and Pendergast, A. M. 2007. Defective T cell development and function in the absence of Abelson kinases. J. Immunol. 179:7334.
43. Grawunder, U., Leu, T. M., Schatz, D. G. et al. 1995. Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement. Immunity 3:601.
44. Lu, L. and Osmond, D. G. 2000. Apoptosis and its modulation during B lymphopoiesis in mouse bone marrow. Immunol. Rev. 175:158.
45. Kim, H. P. and Leonard, W. J. 2002. The basis for TCR-mediated regulation of the IL-2 receptor alpha chain gene: Role of widely separated regulatory elements. EMBO J. 21:3051.
46. Marshall, A. J., Fleming, H. E., Wu, G. E. and Paige, C. J. 1998. Modulation of the IL-7 dose-response threshold during pro-B cell differentiation is dependent on pre-B cell receptor expression. J. Immunol. 161:6038.
47. Backesjo, C. M., Vargas, L., Superti-Furga, G. and Smith, C. I. 2002. Phosphorylation of Bruton's tyrosine kinase by c-Abl. Biochem. Biophys. Res. Commun. 299:510.
48. Plattner, R., Irvin, B. J., Guo, S. et al. 2003. A new link between the c-Abl tyrosine kinase and phosphoinositide signalling through PLC-gamma1. Nat. Cell Biol. 5:309.
49. Jumaa, H., Mitterer, M., Reth, M. and Nielsen, P. J. 2001. The absence of SLP65 and Btk blocks B cell development at the preB cell receptor-positive stage. Eur. J. Immunol. 31:2164.
50. Kersseboom, R., Middendorp, S., Dingjan, G. M. et al. 2003. Bruton's tyrosine kinase cooperates with the B cell linker protein SLP-65 as a tumor suppressor in Pre-B cells. J. Exp. Med. 198:91.
51. Hardin, J. D., Boast, S., Mendelsohn, M., de los Santos, K. and Goff, S. P. 1996. Transgenes encoding both type I and type IV c-abl proteins rescue the lethality of c-abl mutant mice. Oncogene 12:2669.